Aromatherapy for Mental Health Promotion in IVF Patients

Sponsored by Federal University of Minas Gerais

About this trial

Last updated 3 months ago

Study ID

CAEE 94400925.0.0000.0444

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

Accepting

18+ Years

Female

Trial Timing

Started 3 months ago

What is this trial about?

The experience of infertility can cause significant emotional instability, especially for patients awaiting In Vitro Fertilization (IVF) treatment, generating anxiety, stress, and depressive symptoms. This study is a randomized clinical trial assessing the effectiveness of aromatherapy in improving mental health and quality of life in women undergoing infertility treatment. 120 participants will be randomized into three groups (Intervention, Placebo, and Control). The intervention involves the inhalation of true lavender essential oil (Lavandula angustifolia) for four weeks.

What are the participation requirements?

Inclusion Criteria

* Female gender, age over 18 years.

* Diagnosis of infertility with indication for In Vitro Fertilization (IVF).

* Patients on the waiting list at HC-UFMG.

* Agreement not to practice other mind-body or herbal complementary therapies during the study.

* DASS-21 screening score compatible with at least mild anxiety, stress, and/or depression.

* No aversion to inhaling essential oil or synthetic lavender essence.

Exclusion Criteria

* Severe neurological, psychiatric, or clinical disorders (e.g., schizophrenia, severe depression) that prevent participation.

* Use of medications that could confound the primary outcome (e.g., sleep medications, anxiolytics, antidepressants, neuroleptics) in the 30 days prior to or during the study.

* Known allergy to lavender products.

* Pregnancy during the study period.

* Use of essential oils in the last 90 days.